These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8016059)

  • 21. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical trial of glypizide].
    Cañadell Vidal J
    Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of antiaggregants on the course of diabetic microangiopathy].
    Bokarev IN; Velikov VK; Zelenchuk NM; Shubina OI; Saltykov BB; Frolova AI; Polunin GS; Pirogova EP; Nikol'skaia VV; Davydova NG
    Ter Arkh; 1993; 65(3):78-81. PubMed ID: 8059393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oral antidiabetic agents including glucosidase inhibitors].
    Raptis S
    Internist (Berl); 1987 Apr; 28(4):243-53. PubMed ID: 3298124
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of a new sulfonylurea derivative, preparation SPC-703, based on a 5-year observation].
    Horoszek-Maziarz S; Berliński E; Jaromczyk-Slisz J; Rachoń K; Wójcikowski C; Słomiński M; Orłowska-Kunikowska E; Krupa-Wojciechowska B
    Pol Tyg Lek; 1985 May; 40(18):516-8. PubMed ID: 3892514
    [No Abstract]   [Full Text] [Related]  

  • 26. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
    Tseng CH; Huang TS
    Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical trial of the effects of isodibut on several indicators of microcirculation in combined therapy of patients with diabetes mellitus].
    Kakhnovskiĭ IM; Koroleva TV; Golubiatnikova GA; Kalinkina MA
    Klin Med (Mosk); 1996; 74(3):56-8. PubMed ID: 8926708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
    Takamatsu J
    Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R
    Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long term study of a new antidiabetic agent in 1183 cases].
    Riveline B
    Sem Hop Ther; 1974 Feb; 50(2):133-9. PubMed ID: 4612707
    [No Abstract]   [Full Text] [Related]  

  • 31. Direct beneficial effect of insulin on blood rheological disorders in the microcirculation.
    Mantskava M; Pargalava N; McHedlishvili G
    Clin Hemorheol Microcirc; 2004; 30(3-4):431-3. PubMed ID: 15258380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [State of the microcirculatory component of hemostasis and microhemodynamics in patients with diabetic angiopathies].
    Petrova TR; Pavlishchuk SA; Vil'chinskaia MN
    Ter Arkh; 1984; 56(8):129-32. PubMed ID: 6495194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary failure of oral diabetes therapy].
    Bergis K; Heilmann B
    Fortschr Med; 1987 Feb; 105(4):64-8. PubMed ID: 3557262
    [No Abstract]   [Full Text] [Related]  

  • 34. Use oral hypoglycemics with caution..
    Jackson JE; Bressler R
    Geriatrics; 1988 Aug; 43(8):77-83. PubMed ID: 3136057
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of glipizide on platelet function and fibrinolytic activity.
    Ketsa K; Jererat S; Nitiyanant W; Suwanwattana K
    J Med Assoc Thai; 1987 Oct; 70(10):578-82. PubMed ID: 3694080
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
    Spesivtseva VG; Kasabian IN; Mamaeva GG; Kukes VG
    Sov Med; 1980; (2):64-9. PubMed ID: 6987747
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of the effectiveness and tolerability of gliquidone in the treatment of diabetes mellitus type II].
    Iori I; Bosi E; Manicardi E; Del Din G; Dini FL; Portioli I
    Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):277-83. PubMed ID: 2640049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 40. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
    Kabadi UM; Kabadi MU
    J Fam Pract; 1991 Oct; 33(4):349-53. PubMed ID: 1919450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.